CYP19A1 and breast cancer: Several studies suggest that ATF2 may function as an oncogene, worsening the outcome of the disease, as it increases the transcription of genes such as MMP2, MMP13, cyclin A, and aromatase that contribute to the progression and metastasis of breast cancer.